Unspecified GLP-1
Sold by LunaRx · every unspecified glp-1 record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$149
| Medication · Homepage hero starting price (drug/tier not specified) | $149 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Homepage hero starting price (drug/tier not specified) “from $ 149 /mo No insurance needed Cancel anytime · $0 if not approved” | Per month$149 | Charged today$149 |
| Homepage top banner starting price (drug/tier not specified) “Precision GLP-1 + muscle-protective stacks from $199/mo Check eligibility →” | Per month$199 | Charged today$199 |
We earn nothing from this link. LunaRx has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Prescriber | Asynchronous review |
|---|---|
| Cancellation | “You may cancel a subscription at any time up to forty-eight (48) hours before the applicable monthly processing date by turning off the auto-refill feature in your user portal.” |
Not yet checked: pharmacy, states, membership and consult fee.
Recorded from lunarxhealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — LunaRx sells three bundled 'stacks' (semaglutide+peptides, tirzepatide+NAD+, and a 6-month tirzepatide taper program), each described as 'physician-directed' with pricing 'confirmed after your provider review — never a surprise'; neither the Semaglutide nor Tirzepatide product page discloses a dollar figure (both just say 'Available by consultation'). Two different starting prices appear on the homepage ($149/mo in the hero, $199/mo in the top banner) with no indication of which drug or tier either applies to, so both are recorded as unspecified-GLP-1 entries rather than assigned to a specific drug. Terms of Service confirm the site uses a single bundled subscription price covering pharmacy, medical group, and platform fees — consistent with a real program price, not a membership-style exclusion, but the actual amount per drug is never disclosed.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.